Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial.
Eldabe S, Duarte RV, Gulve A, Thomson S, Baranidharan G, Houten R, Jowett S, Sandhu H, Chadwick R, Brookes M, Kansal A, Earle J, Bell J, Robinson J, Walker S, Rhodes S, Taylor RS. Eldabe S, et al. Among authors: robinson j. Pain. 2020 Dec;161(12):2820-2829. doi: 10.1097/j.pain.0000000000001977. Pain. 2020. PMID: 32618875 Free PMC article. Clinical Trial.
To Trial or Not to Trial Before Spinal Cord Stimulation for Chronic Neuropathic Pain: The Patients' View From the TRIAL-STIM Randomized Controlled Trial.
Chadwick R, McNaughton R, Eldabe S, Baranidharan G, Bell J, Brookes M, Duarte RV, Earle J, Gulve A, Houten R, Jowett S, Kansal A, Rhodes S, Robinson J, Griffiths S, Taylor RS, Thomson S, Sandhu H. Chadwick R, et al. Among authors: robinson j. Neuromodulation. 2021 Apr;24(3):459-470. doi: 10.1111/ner.13316. Epub 2020 Dec 1. Neuromodulation. 2021. PMID: 33258531 Free PMC article. Clinical Trial.
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.
Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E; TOMMORROW study investigators. Burns DK, et al. Lancet Neurol. 2021 Jul;20(7):537-547. doi: 10.1016/S1474-4422(21)00043-0. Lancet Neurol. 2021. PMID: 34146512 Clinical Trial.
The histone H3.3 K27M mutation suppresses Ser31phosphorylation and mitotic fidelity, which can directly drive gliomagenesis.
Day CA, Grigore F, Hakkim FL, Paul S, Langfald A, Weberg M, Fadness S, Schwab P, Sepaniac L, Stumpff J, Vaughan KT, Daniels DJ, Robinson JP, Hinchcliffe EH. Day CA, et al. Among authors: robinson jp. Curr Biol. 2024 Dec 19:S0960-9822(24)01575-6. doi: 10.1016/j.cub.2024.11.035. Online ahead of print. Curr Biol. 2024. PMID: 39729988
An application-based taxonomy for brain-computer interfaces.
Robinson JT, Norman SL, Angle MR, Constandinou TG, Denison T, Donoghue JP, Field RM, Forsland A, Kouider S, Millán JDR, Michaels JA, Orsborn AL, Pandarinath C, Pruszynski JA, Rozell CJ, Shah NP, Shanechi MM, Shoaran M, Sheth SA, Stavisky SD, Trautmann E, Vachicouras N, Xie C. Robinson JT, et al. Nat Biomed Eng. 2024 Dec 23. doi: 10.1038/s41551-024-01326-z. Online ahead of print. Nat Biomed Eng. 2024. PMID: 39715900 No abstract available.
9,965 results